Biomind Labs Inc.
BMND
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.50K | -141.10K | -260.50K | -704.90K | -796.00K |
| Total Depreciation and Amortization | 6.60K | 8.80K | 8.80K | 6.60K | 6.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -353.40K | -273.90K | -150.00K | 275.70K | 329.10K |
| Change in Net Operating Assets | 198.70K | 167.70K | 47.30K | -39.30K | -26.80K |
| Cash from Operations | -193.60K | -238.50K | -354.40K | -461.80K | -487.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 140.90K | 218.10K | 307.40K | 328.50K | 501.40K |
| Total Debt Repaid | -- | -- | -- | 1.00K | 1.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.10K | -5.10K | -5.10K | -5.10K | -- |
| Cash from Financing | 135.80K | 213.00K | 302.30K | 324.40K | 502.40K |
| Foreign Exchange rate Adjustments | 25.00K | 23.70K | 28.10K | 18.60K | -43.10K |
| Miscellaneous Cash Flow Adjustments | -- | -44.50K | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -33.00K | -46.40K | -24.10K | -118.80K | -27.60K |